Titlebook: Current Treatment Options for Fuchs Endothelial Dystrophy; Claus Cursiefen,Albert S. Jun Book 2017 Springer International Publishing Switz

arthroplasty

DSAEK (Not Only) in Asian Eyes: What Glide to Use? Optimised Insertion Techniques,treous pressure in Asian patients and a disease profile including advanced endothelial failure secondary to a higher incidence of pseudophakic bullous keratopathy and infectious causes of endothelial cell damage such as cytomegalovirus endotheliitis. The conventional insertion of the corneal tissue

不规则

Intra- and Postoperative Complications and Their Management in DMEK (Including Re-DMEK),l diseases. However, since the introduction of DMEK, corneal surgeons are faced with a set of new procedure-specific complications. From the beginning of the relatively long learning curve, even experienced corneal surgeons will encounter a set of new interface-related intra- and postoperative situa

杀死

气候

Outmoded

manifestation

Long-Term Clear Graft Survival and Chronic Endothelial Cell Loss Following Posterior Lamellar Keratnt for the most frequent indications for corneal transplantation. Instead of replacing all five layers of the cornea (epithelium, Bowman layer, stroma, Descemet membrane, endothelium) by penetrating keratoplasty (PK), which has first been performed by Eduard Zirm [1–3] in 1905, nowadays techniques f

重画只能放弃

字形刻痕

Tissue Engineering of a Healthy Corneal Endothelium for FECD Patients,o native human corneas. Tissue engineering of a corneal endothelium appears to be a quite interesting option. The attractiveness of this approach resides in the possibility of expanding the number of cells obtained from a single donor, as one pair of donor corneas could theoretically treat hundreds

Bombast

ment of complications.Examines emerging medical, cell-based .This book provides state of the art information on modern minimally invasive lamellar transplant techniques for Fuchs endothelial dystrophy (FED), such as Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane

Prologue

https://doi.org/10.1007/978-3-642-94834-3ntury ago by Austrian ophthalmologist Ernst Fuchs, significant strides have been made in our understanding of this complex disease. In this chapter, we review the epidemiology and genetic basis of FECD and discuss potential medical therapies.